Sterile Injectable Solution.
Therapeutically classification: Nonsteroidal anti-inflammatory drug (NSAID)
Composition: Each ml contains:
Target species: Cattle, Horses and Dogs
Baynixin® 5% is used as analgesic, anti-inflammation, antipyretic and also for musculoskeletal disorders in many species.
Treatment of non-infectious mastitis or as an adjuvant therapy with antibiotics in the treatment of infectious mastitis especially coliform mastitis
Treatment of respiratory diseases and reduction of mortality due to edema and acute pulmonary emphysema
Treatment of endotoxic shock
Treatment of arthritis, navicular disease and laminitis
Treatment of viral pneumonia and diarrheas in calves
Pre and post-surgery
Treatment of musculoskeletal disorders, arthritis and laminitis
Treatment of colic
Treatment of endotoxic shock and respiratory diseases
decrease in pain and improvement of inflammation of soft tissues, pre and post ophthalmic and general surgery, post-race treatment
treatment of non-infectious diarrhea of foals
Disk problems, arthritis, heat stroke, diarrhea, shock, control of endotoxins in pyometra, ophthalmic inflammatory conditions in pre and post ophthalmic and general surgery and treatment of parvovirus infection
Mechanism of action:
Flunixin meglumine is a non-steroidal anti-inflammatory drug (NSAID) and cycloxygenase inhibitor. NSAIDs work by inhibiting the production of prostaglandins, thromboxane and other inflammatory mediators. So NSAIDs have analgesic, antipyretic and anti-inflammatory effects.
Dosage & Administration:
Horses: 1.1 mg/kg B.W. (1 ml/45 kg B.W.), daily for up to 5 days by IM or slow IV administration, may be repeated each 12 hours in acute situation.
Foals: 0.25 mg/kg B.W. (1 ml/200 kg B.W.)
Cattle: 1.1-2.2 mg/kg B.W. (1-2 ml/45 kg B.W.) daily for up to 5 days by IM or slow IV administration.
Dogs: 0.5-2 mg/kg B.W. (0.1-0.4 ml /10 kg B.W), daily for up 3 days by slow IV or SC administration.
Meat: 4 days after the last treatment
Milk: 2 day after the last treatment
Do not use in animals showing hypersensitivity to flunixin meglumine.
Do not administer to animals with GI ulcers, cardiac diseases, impaired renal and hepatic function.
Do not use in combination with other steroidal and non-steroidal anti-inflammatory drugs, sulfonamides, anti-coagulant and nephrotoxic agents.
Do not use in race horses 7 days before the match.
Do not inject intra-articular.
Analgesic effect of flunixin meglumine may mask the signs of a serious colic/gastrointestinal problem which could require surgical correction.
Because of the effects of flunixin meglumine on fertility and reproductive function, it is not recommended to use it during the reproductive period of mares.
Keep out of reach and sight of children.
Use only under the prescription of a veterinarian.
Do not store above 25°C, keep away from light and freezing
In use stability:
21 days after first needle insertion
50 ml vial in a box
For veterinary use only
There are no reviews yet.